X-Linked Protoporphyria clinical trials at UCSF
4 in progress, 1 open to eligible people
X-linked protoporphyria is a hereditary condition where sunlight causes intense skin pain. UCSF is enrolling people in studies that test new drugs for lowering the light-sensitive substance in blood. One study tests a drug in participants 12 years and older and records safety data.
Bitopertin in Participants With EPP or XLP (APOLLO)
open to eligible people ages 12 years and up
The goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: - Whether bitopertin increases pain-free sunlight exposure after 6 months of treatment in participants with EPP or XLP. - How PPIX concentration levels change from before bitopertin treatment to after 6 months of treatment. Researchers will compare bitopertin to a placebo look-alike substance that contains no drug. Participants will complete daily questionnaires and attend study visits for assessments.
San Francisco, California and other locations
Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sorry, not currently recruiting here
To evaluate the long-term safety and tolerability of oral dersimelagon.
San Francisco, California and other locations
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
Sorry, accepting new patients by invitation only
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.
San Francisco, California and other locations
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
Sorry, in progress, not accepting new patients
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP.
San Francisco, California and other locations
Last updated: